title: The efficacy of resiniferatoxin in prevention of catheter related bladder discomfort in patients after TURP - a pilot, randomized, open study.
abstract: BACKGROUND
  Resiniferatoxin (RTX) has been shown to have variable efficacy in the treatment of intractable lower urinary tract symptoms and symptoms associated with neurogenic detrusor overactivity. It has also been used successfully in treating overactive bladder (OAB). In order to evaluate the potential and efficiency of RTX in treatment of catheter related bladder discomfort (CRBD) over post-operative period of transurethral resection of the prostate (TURP), we conducted the current pilot, randomized open study.
  
  
  METHODS
  The study was comprised of 48 patients undergoing TURP in a single institute from September 2007 to September 2008. Patients were randomly divided into Group-RTX and Group-control. CRBD was classified into 4 degrees: degree 0, 1, 2, and 3. Patients with the most severed CRBD (degree-3) were treated with tolterodine.
  
  
  RESULTS
  There were no statistical difference of patients' age, prostate volume, IPSS score, storage score and void score in IPSS, and QOL score between the two study groups(P=0.213, 0.356, 0.471, 0.554, 0.055 and 0.380, respectively). RTX pre-treatment reduced incidence of CRBD. 25% of the patients in RTX group had CRBD, at 6 hours/1 day and 3 days after TURP, significantly lower than the control group in which 75% of the patients during the same period (P=0.001). During the three days post-operative period, RTX also reduced severity of CRBD, compared with the control group. No patient in Group RTX sufferred CRBD of degree 3, a clear contrast to the control group in which 7 patients had degree 3 CRBD, during three days post-operative. Finally, less patients in RTX group required tolterodine, compared with control, P=0.009. Interestingly, the difference of CRBD incidence between Group RTX (50%) and control (75%) diminished 5 days after TURP, P=0.135.
  
  
  CONCLUSIONS
  Pretreatment with intravesical resiniferatoxin significantly reduces the incidence and severity of catheter related bladder discomfort in patients after TURP.
authors.affiliation: Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
authors.forename: Ning
authors.initials: N
authors.lastname: Zhang
authors.affiliation: Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
authors.forename: Peng
authors.initials: P
authors.lastname: Zhang
authors.affiliation: Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
authors.forename: Xiaodong
authors.initials: X
authors.lastname: Zhang
authors.affiliation: Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
authors.forename: Yong
authors.initials: Y
authors.lastname: Yang
keywords: Catheter related bladder discomfort; RTX; TURP
references.citation: J Urol. 2002 Aug;168(2):575-9
references.pmid: 12131313
references.citation: Urology. 2000 May;55(5A Suppl):60-4; discussion 66
references.pmid: 10767456
references.citation: BJU Int. 2008 Nov;102(9):1128-32
references.pmid: 18647298
references.citation: Eur Urol. 2006 Dec;50(6):1299-305
references.pmid: 16697519
references.citation: J Urol. 2000 Sep;164(3 Pt 1):676-9
references.pmid: 10953124
references.citation: N Z Med J. 2005 Feb 17;119(1229):U1871
references.pmid: 16498471
references.citation: World J Urol. 2001 Apr;19(2):141-7
references.pmid: 11374317
references.citation: Urology. 2005 Feb;65(2):400-5
references.pmid: 15708075
references.citation: Anesth Analg. 2005 Oct;101(4):1065-7, table of contents
references.pmid: 16192522
references.citation: Exp Neurol. 2008 Dec;214(2):301-8
references.pmid: 18824169
references.citation: Urology. 2004 Mar;63(3 Suppl 1):32-41
references.pmid: 15013650
references.citation: Brain Res. 1997 Mar 28;752(1-2):52-60
references.pmid: 9106440
references.citation: World J Urol. 2001 Nov;19(5):319-23
references.pmid: 11760780
references.citation: Br J Perioper Nurs. 2004 Jun;14(6):259-60, 262-4
references.pmid: 15704735
references.citation: J Urol. 2001 Dec;166(6):2368-9
references.pmid: 11696787
references.citation: J Urol. 2004 Jan;171(1):251-5
references.pmid: 14665887
references.citation: Br J Anaesth. 2006 Mar;96(3):377-80
references.pmid: 16415311
references.citation: Eur Urol. 2000 Oct;38(4):444-52
references.pmid: 11025384
references.citation: BJU Int. 2004 Jul;94(1):153-7
references.pmid: 15217452
references.citation: J Urol. 2003 Sep;170(3):835-9
references.pmid: 12913711
references.citation: Obstet Gynecol. 2003 Sep;102(3):605-11
references.pmid: 12962951
references.citation: Br J Anaesth. 2006 May;96(5):587-9
references.pmid: 16531445
references.citation: Mayo Clin Proc. 2001 Apr;76(4):358-63
references.pmid: 11322350
references.citation: Eur Urol. 2004 Jul;46(1):88-93; discussion 93-4
references.pmid: 15183552
references.citation: J Pain Symptom Manage. 2003 Jan;25(1):1-3
references.pmid: 12565179
references.citation: Drug Saf. 2004;27(13):1043-57
references.pmid: 15471509
references.citation: Br J Pharmacol. 2003 Jan;138(1):172-6
references.pmid: 12522087